# A Study of r-PA Treating Patients With Acute Ischemic Stroke（RAISE）

Study · id `cardio:ct-nct05295173` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05295173](<https://clinicaltrials.gov/study/NCT05295173>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05295173

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1412 participants.

## Technical summary

Registry record NCT05295173. Randomized; no masking; primary purpose treatment. Start 2022-03-21 (actual); primary completion 2023-06-22 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1412 participants (enrolled count; ClinicalTrials.gov record NCT05295173, source copy `cardio:ctgov-nct05295173-2024-03-04`, retrieved 2026-10-26)
- Started: 2022-03-21 (actual) (ClinicalTrials.gov record NCT05295173, source copy `cardio:ctgov-nct05295173-2024-03-04`, retrieved 2026-10-26)
- Primary completion: 2023-06-22 (actual) (ClinicalTrials.gov record NCT05295173, source copy `cardio:ctgov-nct05295173-2024-03-04`, retrieved 2026-10-26)
- Completion: 2023-06-22 (actual) (ClinicalTrials.gov record NCT05295173, source copy `cardio:ctgov-nct05295173-2024-03-04`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05295173, source copy `cardio:ctgov-nct05295173-2024-03-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05295173-2024-03-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study of r-PA Treating Patients With Acute Ischemic Stroke（RAISE）
- Condition: Acute Ischemic Stroke
- Intervention (Drug): Injection of recombinant human tissue plasminogen kinase derivatives
- Intervention (Drug): Recombinant human tissue plasminogen activator
- Lead sponsor: Angde Biotech Pharmaceutical Co., Ltd.
- Lead sponsor class: INDUSTRY
- Collaborator: Beijing Tiantan Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as a collaborator: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Reteplase versus Alteplase for Acute Ischemic Stroke (`cardio:pubmed-38884332`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy and Safety of Reteplase Versus Alteplase in Acute Ischemic Stroke Based on Fibrinogen Levels: The RAISE Trial Subgroup (`cardio:pubmed-42089199`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: df18d88e15b6ad6d76463b96b5573beb6ac05a7179cdc446db7dd7c553319285
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
